OpenEvidence, an AI-driven platform designed to assist doctors in diagnosing and treating patients, has successfully raised $200 million in funding, achieving a valuation of $6 billion. The platform utilizes advanced technology similar to ChatGPT to enhance medical decision-making and improve patient outcomes.

Assort Health has secured $76 million in Series B funding to enhance its AI-driven patient experience platform, Assort OS, aiming to simplify healthcare interactions such as scheduling appointments and managing prescriptions. The company leverages agentic AI to reduce patient wait times and improve access to care, addressing long-standing frustrations in the healthcare system. With this funding, Assort Health plans to expand its team and further develop its technology to streamline operations for healthcare providers.